Global Codeine Industry Growth and Trends Forecast to 2031
Description
Summary
Codeine is an opiate used to treat pain, coughing, and diarrhea. It is typically used to treat mild to moderate degrees of pain.
According to APO Research, The global Codeine market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.
North American market for Codeine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Asia-Pacific market for Codeine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Europe market for Codeine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
The major global manufacturers of Codeine include Taiji, Mallinckrodt, TEVA, Johnson & Johnson, Medreich, Sanofi Aventis, Cipla, Hikma and Pharmaceutical Associates, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Codeine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Codeine.
The Codeine market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Codeine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Codeine Segment by Company
Taiji
Mallinckrodt
TEVA
Johnson & Johnson
Medreich
Sanofi Aventis
Cipla
Hikma
Pharmaceutical Associates
Novartis
Apotex
Mylan
Aristo Pharma GmbH
Lannett Company
Laboratoire Riva
Codeine Segment by Ingredient
Single-ingredient Codeine
Multi-ingredient Medications
Codeine Segment by Application
Narcotic Analgesic
Antitussive
Others
Codeine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Codeine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Codeine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Codeine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Codeine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Codeine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Codeine is an opiate used to treat pain, coughing, and diarrhea. It is typically used to treat mild to moderate degrees of pain.
According to APO Research, The global Codeine market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.
North American market for Codeine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Asia-Pacific market for Codeine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Europe market for Codeine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
The major global manufacturers of Codeine include Taiji, Mallinckrodt, TEVA, Johnson & Johnson, Medreich, Sanofi Aventis, Cipla, Hikma and Pharmaceutical Associates, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Codeine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Codeine.
The Codeine market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Codeine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Codeine Segment by Company
Taiji
Mallinckrodt
TEVA
Johnson & Johnson
Medreich
Sanofi Aventis
Cipla
Hikma
Pharmaceutical Associates
Novartis
Apotex
Mylan
Aristo Pharma GmbH
Lannett Company
Laboratoire Riva
Codeine Segment by Ingredient
Single-ingredient Codeine
Multi-ingredient Medications
Codeine Segment by Application
Narcotic Analgesic
Antitussive
Others
Codeine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Codeine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Codeine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Codeine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Codeine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Codeine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Table of Contents
113 Pages
- 1 Market Overview
- 2 Global Market Dynamics
- 3 Market Competitive Landscape by Company
- 4 Codeine Regional Status and Outlook
- 5 Codeine by Application
- 6 Company Profiles
- 7 North America by Country
- 8 Europe by Country
- 9 Asia-Pacific by Country
- 10 South America by Country
- 11 Middle East and Africa by Country
- 12 Value Chain and Sales Channels Analysis
- 13 Concluding Insights
- 14 Appendix
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Codeine Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Codeine Sales Estimates and Forecasts (2020-2031)
1.3 Codeine Market by Ingredient
1.3.1 Single-ingredient Codeine
1.3.2 Multi-ingredient Medications
1.4 Global Codeine Market Size by Ingredient
1.4.1 Global Codeine Market Size Overview by Ingredient (2020-2031)
1.4.2 Global Codeine Historic Market Size Review by Ingredient (2020-2025)
1.4.3 Global Codeine Forecasted Market Size by Ingredient (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Codeine Sales Breakdown by Ingredient (2020-2025)
1.5.2 Europe Codeine Sales Breakdown by Ingredient (2020-2025)
1.5.3 Asia-Pacific Codeine Sales Breakdown by Ingredient (2020-2025)
1.5.4 South America Codeine Sales Breakdown by Ingredient (2020-2025)
1.5.5 Middle East and Africa Codeine Sales Breakdown by Ingredient (2020-2025)
2.1 Codeine Industry Trends
2.2 Codeine Industry Drivers
2.3 Codeine Industry Opportunities and Challenges
2.4 Codeine Industry Restraints
3.1 Global Top Players by Codeine Revenue (2020-2025)
3.2 Global Top Players by Codeine Sales (2020-2025)
3.3 Global Top Players by Codeine Price (2020-2025)
3.4 Global Codeine Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Codeine Major Company Production Sites & Headquarters
3.6 Global Codeine Company, Product Type & Application
3.7 Global Codeine Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Codeine Market CR5 and HHI
3.8.2 Global Top 5 and 10 Codeine Players Market Share by Revenue in 2024
3.8.3 2023 Codeine Tier 1, Tier 2, and Tier 3
4.1 Global Codeine Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Codeine Historic Market Size by Region
4.2.1 Global Codeine Sales in Volume by Region (2020-2025)
4.2.2 Global Codeine Sales in Value by Region (2020-2025)
4.2.3 Global Codeine Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Codeine Forecasted Market Size by Region
4.3.1 Global Codeine Sales in Volume by Region (2026-2031)
4.3.2 Global Codeine Sales in Value by Region (2026-2031)
4.3.3 Global Codeine Sales (Volume & Value), Price and Gross Margin (2026-2031)
5.1 Codeine Market by Application
5.1.1 Narcotic Analgesic
5.1.2 Antitussive
5.1.3 Others
5.2 Global Codeine Market Size by Application
5.2.1 Global Codeine Market Size Overview by Application (2020-2031)
5.2.2 Global Codeine Historic Market Size Review by Application (2020-2025)
5.2.3 Global Codeine Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Codeine Sales Breakdown by Application (2020-2025)
5.3.2 Europe Codeine Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Codeine Sales Breakdown by Application (2020-2025)
5.3.4 South America Codeine Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Codeine Sales Breakdown by Application (2020-2025)
6.1 Taiji
6.1.1 Taiji Comapny Information
6.1.2 Taiji Business Overview
6.1.3 Taiji Codeine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Taiji Codeine Product Portfolio
6.1.5 Taiji Recent Developments
6.2 Mallinckrodt
6.2.1 Mallinckrodt Comapny Information
6.2.2 Mallinckrodt Business Overview
6.2.3 Mallinckrodt Codeine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Mallinckrodt Codeine Product Portfolio
6.2.5 Mallinckrodt Recent Developments
6.3 TEVA
6.3.1 TEVA Comapny Information
6.3.2 TEVA Business Overview
6.3.3 TEVA Codeine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 TEVA Codeine Product Portfolio
6.3.5 TEVA Recent Developments
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Comapny Information
6.4.2 Johnson & Johnson Business Overview
6.4.3 Johnson & Johnson Codeine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Johnson & Johnson Codeine Product Portfolio
6.4.5 Johnson & Johnson Recent Developments
6.5 Medreich
6.5.1 Medreich Comapny Information
6.5.2 Medreich Business Overview
6.5.3 Medreich Codeine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Medreich Codeine Product Portfolio
6.5.5 Medreich Recent Developments
6.6 Sanofi Aventis
6.6.1 Sanofi Aventis Comapny Information
6.6.2 Sanofi Aventis Business Overview
6.6.3 Sanofi Aventis Codeine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Sanofi Aventis Codeine Product Portfolio
6.6.5 Sanofi Aventis Recent Developments
6.7 Cipla
6.7.1 Cipla Comapny Information
6.7.2 Cipla Business Overview
6.7.3 Cipla Codeine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Cipla Codeine Product Portfolio
6.7.5 Cipla Recent Developments
6.8 Hikma
6.8.1 Hikma Comapny Information
6.8.2 Hikma Business Overview
6.8.3 Hikma Codeine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Hikma Codeine Product Portfolio
6.8.5 Hikma Recent Developments
6.9 Pharmaceutical Associates
6.9.1 Pharmaceutical Associates Comapny Information
6.9.2 Pharmaceutical Associates Business Overview
6.9.3 Pharmaceutical Associates Codeine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Pharmaceutical Associates Codeine Product Portfolio
6.9.5 Pharmaceutical Associates Recent Developments
6.10 Novartis
6.10.1 Novartis Comapny Information
6.10.2 Novartis Business Overview
6.10.3 Novartis Codeine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Novartis Codeine Product Portfolio
6.10.5 Novartis Recent Developments
6.11 Apotex
6.11.1 Apotex Comapny Information
6.11.2 Apotex Business Overview
6.11.3 Apotex Codeine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Apotex Codeine Product Portfolio
6.11.5 Apotex Recent Developments
6.12 Mylan
6.12.1 Mylan Comapny Information
6.12.2 Mylan Business Overview
6.12.3 Mylan Codeine Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Mylan Codeine Product Portfolio
6.12.5 Mylan Recent Developments
6.13 Aristo Pharma GmbH
6.13.1 Aristo Pharma GmbH Comapny Information
6.13.2 Aristo Pharma GmbH Business Overview
6.13.3 Aristo Pharma GmbH Codeine Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Aristo Pharma GmbH Codeine Product Portfolio
6.13.5 Aristo Pharma GmbH Recent Developments
6.14 Lannett Company
6.14.1 Lannett Company Comapny Information
6.14.2 Lannett Company Business Overview
6.14.3 Lannett Company Codeine Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Lannett Company Codeine Product Portfolio
6.14.5 Lannett Company Recent Developments
6.15 Laboratoire Riva
6.15.1 Laboratoire Riva Comapny Information
6.15.2 Laboratoire Riva Business Overview
6.15.3 Laboratoire Riva Codeine Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Laboratoire Riva Codeine Product Portfolio
6.15.5 Laboratoire Riva Recent Developments
7.1 North America Codeine Sales by Country
7.1.1 North America Codeine Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Codeine Sales by Country (2020-2025)
7.1.3 North America Codeine Sales Forecast by Country (2026-2031)
7.2 North America Codeine Market Size by Country
7.2.1 North America Codeine Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Codeine Market Size by Country (2020-2025)
7.2.3 North America Codeine Market Size Forecast by Country (2026-2031)
8.1 Europe Codeine Sales by Country
8.1.1 Europe Codeine Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Codeine Sales by Country (2020-2025)
8.1.3 Europe Codeine Sales Forecast by Country (2026-2031)
8.2 Europe Codeine Market Size by Country
8.2.1 Europe Codeine Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Codeine Market Size by Country (2020-2025)
8.2.3 Europe Codeine Market Size Forecast by Country (2026-2031)
9.1 Asia-Pacific Codeine Sales by Country
9.1.1 Asia-Pacific Codeine Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Codeine Sales by Country (2020-2025)
9.1.3 Asia-Pacific Codeine Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Codeine Market Size by Country
9.2.1 Asia-Pacific Codeine Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Codeine Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Codeine Market Size Forecast by Country (2026-2031)
10.1 South America Codeine Sales by Country
10.1.1 South America Codeine Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Codeine Sales by Country (2020-2025)
10.1.3 South America Codeine Sales Forecast by Country (2026-2031)
10.2 South America Codeine Market Size by Country
10.2.1 South America Codeine Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Codeine Market Size by Country (2020-2025)
10.2.3 South America Codeine Market Size Forecast by Country (2026-2031)
11.1 Middle East and Africa Codeine Sales by Country
11.1.1 Middle East and Africa Codeine Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Codeine Sales by Country (2020-2025)
11.1.3 Middle East and Africa Codeine Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Codeine Market Size by Country
11.2.1 Middle East and Africa Codeine Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Codeine Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Codeine Market Size Forecast by Country (2026-2031)
12.1 Codeine Value Chain Analysis
12.1.1 Codeine Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Codeine Production Mode & Process
12.2 Codeine Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Codeine Distributors
12.2.3 Codeine Customers
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.


